Alzheimer's disease

After EU setback, Eisai/Biogen build case for Leqembi
Pharmaphorum
Wed, 07/31/24 - 10:25 am
Eisai
Biogen
Alzheimer's disease
Leqembi
Europe
Novo’s Older GLP-1 Drug Slows Cognitive Decline in Phase IIb Alzheimer’s Trial
BioSpace
Tue, 07/30/24 - 11:48 am
Novo Nordisk
liraglutide
clinical trials
Alzheimer's disease
Eisai 'extremely disappointed' by EMA's decision on Alzheimer's drug
Biopharma Reporter
Tue, 07/30/24 - 11:37 am
Eisai
EMA
Europe
Leqembi
Biogen
Alzheimer's disease
FDA approves Alpha Cognition's Zunveyl for mild-to-moderate Alzheimer disease
Neurology Live
Mon, 07/29/24 - 10:58 am
Alpha Cognition
FDA
Zunveyl
ALPHA-1062
Alzheimer's disease
Blood tests may have an edge spotting Alzheimer's
Axios
Mon, 07/29/24 - 10:46 am
Medtech
diagnostics
Alzheimer's disease
AbbVie axes midstage Alzheimer's program amid 'evolving landscape'
Fierce Biotech
Thu, 07/25/24 - 11:30 am
AbbVie
Alzheimer's disease
ABBV-916
Cassava Execs Step Down Amid DOJ Probe of Possible Alzheimer’s Drug Fraud
BioSpace
Thu, 07/18/24 - 11:07 am
Cassava Sciences
DOJ
fraud
Alzheimer's disease
simufilam
Novo leads $100m financing for Alzheimer's player Asceneuron
Pharmaphorum
Tue, 07/16/24 - 11:56 am
Novo Holdings
Asceneuron
funding
Alzheimer's disease
5 Neuro Data Readouts to Watch in the Second Half of 2024
BioSpace
Mon, 07/15/24 - 11:43 am
neurology
clinical trials
Athira Pharma
fosgonimeton
Alzheimer's disease
AbbVie
Cerevel Therapeutics
emraclidine
schizophrenia
Neumora Therapeutics
major depressive disorder
navacaprant
Amylx
AMX003
Wolfram syndrome
Vigil Neuroscience
iluzanebart
Leqembi sales inch higher; Spark’s pivot leads to layoffs
BioPharma Dive
Fri, 07/12/24 - 11:29 am
Eisai
Biogen
Leqembi
Alzheimer's disease
Roche
Spark Therapeutics
gene therapy
layoffs
Leqembi gains approval for Alzheimer’s treatment in Israel
Pharmaceutical Business Review
Fri, 07/12/24 - 11:12 am
Eisai
Israel
Alzheimer's disease
Leqembi
BioArctic
FDA approval is just the beginning. Now Lilly’s Kisunla faces the tough Alzheimer’s market
Pharma Voice
Tue, 07/9/24 - 11:24 am
Eli Lilly
Kisunla
Alzheimer's disease
Eli Lilly Alzheimer's drug approved by US FDA
Reuters
Tue, 07/2/24 - 03:09 pm
Eli Lilly
donanemab
Alzheimer's disease
FDA
Kisunla
Two Senior Cassava Employees Subjects in Federal Probes After Former Advisor Indicted for Fraud
BioSpace
Tue, 07/2/24 - 11:37 am
Cassava Sciences
Alzheimer's disease
legal
fraud
Eisai and Biogen launch Alzheimer's drug Leqembi in China
Reuters
Fri, 06/28/24 - 11:18 am
Eisai
Biogen
Alzheimer's disease
Leqembi
China
Where the future of Alzheimer's drugs is heading
Axios
Fri, 06/28/24 - 11:15 am
Alzheimer's disease
drug development
Eli Lilly
5 FDA Decisions to Watch in the Second Half of 2024
BioSpace
Mon, 06/24/24 - 11:29 am
FDA
Eli Lilly
donanemab
Alzheimer's disease
Adaptimmune
afami-cel
advanced synovial sarcoma
Lykos Therapeutics
MDMA
PTSD
Bristol Myers Squibb
KarXT
schizophrenia
Daiichi Sankyo
AstraZeneca
Dato-DXd
non-small cell lung cancer
What Would a Donanemab Approval Mean for Leqembi?
BioSpace
Mon, 06/24/24 - 10:47 am
Eli Lilly
donanemab
Biogen
Eisai
Leqembi
FDA
Alzheimer's disease
How Roche is finding better ways to diagnose brain conditions like Alzheimer’s and Parkinson’s disease
Pharma Voice
Tue, 06/18/24 - 11:34 am
Roche
biomarkers
Alzheimer's disease
Parkinson's Disease
R&D
Eli Lilly Scores Another Major Win and Lines Up Its Next Blockbuster
Motley Fool
Sun, 06/16/24 - 08:54 pm
Eli Lilly
Alzheimer's disease
donanemab

Pages